Paradoxical accumulation of the cyclin-dependent kinase inhibitor p27(kip1) during the cAMP-dependent mitogenic stimulation of thyroid epithelial cells

Journal of Cell Science

Volumn 109, Issue 7, 1996, Pages 1759-1764

  Depoortere, Fabienne ^a   Dumont, Jacques E ^a   Roger, Pierre P ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

CDK; Cell cycle; CKI; Epidermal growth factor; Immunocytochemical localization; Proliferation; Thyrotropin

Indexed keywords

CYCLIC AMP; CYCLIN DEPENDENT KINASE; EPIDERMAL GROWTH FACTOR; THYROTROPIN; TRANSFERASE INHIBITOR;

ANIMAL CELL; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA SYNTHESIS; DOG; EPITHELIUM CELL; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; SECOND MESSENGER; THYROID CELL;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CELLS, CULTURED; CYCLIC AMP; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; DOGS; EPITHELIAL CELLS; EPITHELIUM; MICROTUBULE-ASSOCIATED PROTEINS; THYROID GLAND; THYROTROPIN; TUMOR SUPPRESSOR PROTEINS;

EID: 0029890048     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Aprelikova, O., Xiong, Y. and Liu, E. T. (1995). Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block phosphorylation of cyclin-dependent kinases by the CDK-activating kinase. J. Biol. Chem. 270, 18195-18197.
2. Baptist, M., Dumont, J. E. and Roger, P. P. (1993). Demonstration of cell cycle kinetics in thyroid primary culture by immunostaining of proliferating cell nuclear antigen: differences in cyclic AMP-dependent and -independent mitogenic stimulations. J. Cell Sci. 105, 69-80.
3. Baptist, M., Dumont, J. E. and Roger, P. P. (1995). Intercellular heterogeneity of early mitogenic events: cAMP generalizes the EGF effect on c-Fos protein appearance but not on MAP kinase phosphorylation and nuclear translocation in dog thyroid epithelial cells. Exp. Cell Res. 221, 160-171.
4. Baptist, M., Lamy, F., Gannon, J., Hunt, T., Dumont, J. E. and Roger, P. P. (1996). Expression and subcellular localization of CDK2 and cdc2 kinases and their common partner cyclin A in thyroid epithelial cells: Comparison of cyclic-AMP-dependent and -independent cell cycles. J. Cell. Physiol. 166, 256-273.
5. Boynton, A. L. and Whitfield, J. F. (1983). The role of cyclic AMP in cell proliferation: A critical assessment of the evidence. Advan. Cyclic Nucl. Res. 15, 193-294.
6. Christoffersen, J., Smeland, E. B., Stokke, T., Taskén, K., Anderson, K. B. and Blomhoff, H. K. (1994). Retinoblastoma protein is rapidly dephosphorylated by elevated cyclic adenosine monophosphate levels in human B-lymphoid cells. Cancer Res. 54, 2245-2250.
7. Depoortere, F., Burikhanov, R., Baptist, M. and Roger, P. P. (1995). Transforming growth factor β specifically inhibits the TSH/cAMP-dependent proliferation of dog thyrocytes in primary culture: its effects on cell cycle regulatory proteins. Thyroid 5 (suppl. 1), S-206 (abstract).
8. Dumont, J. E., Jauniaux, J. C. and Roger, P. P. (1989). The cyclic AMP-mediated stimulation of cell proliferation. Trends Biochem. Sci. 14, 67-71.
9. Dumont, J. E., Lamy, F., Roger, P. P. and Maenhaut, C. (1992). Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol. Rev. 72, 667-697.
10. Farrar, W. L., Evans, S. W., Rapp, U. R. and Cleveland, J. L. (1987). Effects of antiproliferative cyclic AMP on interleukine-2-stimulated gene expression. J. Immunol. 139, 2075-2080.
11. Fisher, R. P. and Morgan, D. O. (1994). A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell 78, 713-724.
12. Galaktionov, K., Lee, A. K., Eckstein, J., Draetta, G., Meckler, J., Loda, M. and Beach, D. (1995). CDC25 phosphatases as potential human oncogenes. Science 269, 1575-1577.
13. Grana, X. and Reddy, E. P. (1995). Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 11, 211-219.
14. Guadagno, T. M., Ohtsubo, M., Roberts, J. M. and Assoian, R. K. (1993). A link between cyclin A expression and adhesion-dependent cell cycle progression. Science 262, 1572-1575.
15. Hall, M., Bates, S. and Peters, G. (1995). Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene 11, 1581-1588.
16. 1 cyclin-dependent kinases. Cell 75, 805-816.
17. 3H-thymidine incorporation in human fibroblasts. J. Cell. Physiol. 138, 17-23.
18. WAF1/CIP1/SD1. Oncogene 11, 1409-1415.
19. Holte, H., Torjesen, P., Blomhoff, H. K., Rund, E., Fundernd, S. and Smeland, E. B. (1988). Cyclic AMP has the ability to influence multiple events during B cells stimulation. Eur. J. Immunol. 18, 1359-1366.
20. kip1) of cyclin-dependent kinase 4 activation. Cell 79, 487-496.
21. Kranenburg, O., Scharnhorst, V., Van der Eb, A. J. and Zantema, A. (1995). Inhibition of cyclin-dependent kinase activity triggers neuronal differentiation of mouse neuroblastoma cells. J. Cell Biol. 131, 227-234.
22. Lamy, F., Wilkin, F., Baptist, M., Posada, J., Roger, P. P. and Dumont, J. E. (1993). Phosphorylation of mitogen-activated protein kinase is involved in the epidermal growth factor and phorbol ester, but not in the thyrotropin/cAMP, thyroid mitogenic pathway. J. Biol. Chem. 268, 8398-8401.
23. kip1 cyclin-dependent kinase inhibitor prevented by nipamycin. Nature 372, 570-573.
24. Pagano, M., Tam, S. W., Theodoras, A. M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P. R., Draetta, G. F. and Rolfe, M. (1995). Role of ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269, 682-685.
25. Paterlini, P., Suberville, A. M., Zindy, F., Melle, J., Sonnier, M., Marie, J. P., Dreyfus, F. and Bréchot, C. (1993). Cyclin A expression in human hematological malignancies: a new marker of cell proliferation. Cancer Res. 53, 235-238.
26. Pines, J. (1995). Cyclins and cyclin-dependent kinases: a biochemical view. Biochem. J. 308, 697-711.
27. Pohl, V., Roger, P. P., Christophe, D., Pattyn, G., Vassart, G. and Dumont, J. E. (1990). Differentiation expression during proliferative activity induced through different pathways: In situ hybridization study of thyroglobulin gene expression in thyroid epithelial cells. J. Cell Biol. 111, 663-672.
28. Pohl, V., Abramovicz, M., Vassart, G., Dumont, J. E. and Roger, P. P. (1993). Thyroperoxidase mRNA in quiescent and proliferating thyroid epithelial cells: Expression and subcellular localization studied by in situ hybridization. Eur. J. Cell Biol. 62, 94-104.
29. kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59-66.
30. kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8, 9-22.
31. kip1 in C3H 10T1/2 mouse fibroblasts. Cancer Res. 55, 1413-1416.
32. kip1. Mol. Cell. Biol. 15, 4347-4352.
33. Reuse, S., Maenhaut, C. and Dumont, J. E. (1990). Regulation of protooncogenes c-fos and c-myc expression by protein tyrosine kinase, protein kinase C and cyclic AMP mitogenic pathways in dog primary thyrocytes: a positive and negative control by cyclic AMP on c-myc expression. Exp. Cell Res. 189, 33-40.
34. Reuse, S., Pirson, I. and Dumont, J. E. (1991). Differential regulation of protooncogenes c-jun and jun D expressions by protein tyrosine kinase, protein kinase C and cyclic AMP mitogenic pathways in dog primary thyrocytes: TSH and cyclic AMP induce proliferation but downregulate c-jun expression. Exp. Cell Res. 196, 210-215.
35. 1 stage of the cell cycle and overrides constitutive c-myc expression. Mol. Cell. Biol. 12, 2351-2358.
36. Roger, P. P., Servais, P. and Dumont, J. E. (1983). Stimulation by thyrotropin and cyclic AMP of the proliferation of quiescent canine thyroid cells cultured in a defined medium containing insulin. FEBS Lett. 157, 323-327.
37. Roger, P. P., Servais, P. and Dumont, J. E. (1987a). Regulation of dog thyroid epithelial cell cycle by forskolin, an adenylate cyclase activator. Exp. Cell Res. 172, 292-292.
38. Roger, P. P, Servais, P. and Dumont, J. E. (1987b). Induction of DNA synthesis in dog thyrocytes in primary culture: synergistic effects of thyrotropin and cyclic AMP with epidermal growth factor and insulin. J. Cell Physiol. 130, 58-67.
39. Roger, P. P., Baptist, M. and Dumont, J. E. (1992). A mechanism generating heterogeneity in thyroid epithelial cells: Suppression of the thyrotropin/cAMP-dependent mitogenic pathway after cell division induced by cAMP-independent factors. J. Cell Biol. 117, 383-393.
40. Roger, P. P., Reuse, S., Maenhaut, C. and Dumont, J. E. (1995). Multiple facets of the modulation of growth by cAMP. Vitam. Horm. 51, 59-191.
41. Slingerland, J., Hengst, L., Pan, C. H., Alexander, D., Stampfer, M. and Reed, S. I. (1994). A novel inhibitor of cyclin-cdk activity detected in transforming growth factor β-arrested epithelial cells. Mol. Cell. Biol. 14, 3683-3694.
42. 1 cyclin-cdk complexes. EMBO J. 14, 4814-4826.
43. ink4. Cancer Res. 54, 5816-5820.
44. 1 cyclin-cdk protein kinase activity, is related to p21.
45. Vairo, G., Argyriou, S., Bordun, A. M., Whitty, G. and Hamilton, J. A. (1990). Inhibition of the signaling pathways for macrophage proliferation by cyclic AMP. J. Biol. Chem. 265, 2692-2701.
46. 3H-thymidine labelling patterns to determine rapid changes in the rate of onset of DNA replication. J. Cell. Physiol. 141, 371-382.
47. Wu, J., Dent, P., Jelinek, T., Wolfman, A., Weber, M. J. and Sturgill, T. W. (1993). Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3',5'-monophosphate. Science 262, 1065-1068.